Training & Education

Training & Education

Patient-focused resources, tips from experts, and challenging clinical questions from ASH Clinical News

Choosing Your Own Training Adventure: Where Do You Start?

The American Society of Hematology (ASH) created the ASH Trainee Council to advocate for the issues and concerns of hematology/oncology trainees, including mentorship, publishing,...

Tips and Insights from ASH Annual Meeting Regulars

Attending the American Society of Hematology (ASH) annual meeting for the first time can be both exciting and overwhelming. ASH Clinical News spoke with Surbhi Sidana, MBBS, a...

The Wide World of Medical Education

You have to do what you love. In medicine, we are fortunate to have many career opportunities in addition to patient care – research,...

Training for a Career You Love: What Can the ASH Trainee Council Do For...

In your opinion, what are the biggest obstacles facing today’s trainees? Securing funding to acquire the necessary protected time for research will be more difficult...

Advice From the Future

We asked innovators and mentors in hematology and oncology: What advice would you give to early-career hematologists? Here’s what they had to say! “I teach...

From TraineE-News: Navigating Your First Job in Hematology

Reprinted from TraineE-News, a quarterly collection of articles written by and for trainees, and curated by the ASH Trainee Council, that is delivered to trainees...

A Day in the Life: Martin Palmeri, MD

Trainees often wonder about the lifestyle of a hematologist, so we asked former Trainee Council member Martin Palmeri, MD, to give us a snapshot...

Hemophilia: Understanding Inhibitors

Patients with hemophilia (a blood clotting disorder) can develop inhibitors (also called antibodies) when they have an immune response to factor concentrates (the treatment...

How would you treat a patient with aplastic anemia who refuses transfusions for religious...

This month, Neil A. Zakai, MD, discusses how to treat a patient with aplastic anemia who has religious objections to allogeneic blood product. And don't...

What are treatment options for a patient with c-Myc positive diffuse large B-cell lymphoma?

This month David Straus, MD, discusses treatment options for a patient with c-Myc positive diffuse large B-cell lymphoma. And don't forget to check out next...
Advertisement

Current Issue

August 2017, Volume 3, Issue 10

This issue features a comparison between American and European drug approval processes, a conversation with a lymphoma doctor running for Congress, highlights from recent hematology/oncology meetings, and more.